CIK 0001638287
- Non-accelerated filer
- Smaller reporting company
MetaVia Inc.
Sign in to watch- Ticker
- MTVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472389984
- Phone
- +1 857-702-9600
- Business address
- 545 CONCORD AVENUE, SUITE 210, CAMBRIDGE, MA, 02138
- Former names
- NeuroBo Pharmaceuticals, Inc., Gemphire Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-10 | Bisgaier Charles PhD Chair & Chief Scientific Off. | Conversion | +16,144 | $6.71 | $108K | 82,220 |
| 2016-08-10 | Bisgaier Charles PhD Chair & Chief Scientific Off. | Conversion | +19,228 | $6.71 | $129K | 19,228 |
| 2016-08-10 | Bisgaier Charles PhD Chair & Chief Scientific Off. | Purchase | +51,750 | $10.00 | $518K | 1,244,440 |
| 2016-08-10 | Bisgaier Charles PhD Chair & Chief Scientific Off. | Conversion · Series A Convertible Preferred Stock | −59,561 | 0 | ||
| 2016-08-10 | Bisgaier Charles PhD Chair & Chief Scientific Off. | Conversion · 8% Convertible Subordinated Promissory Notes | −0 | 0 | ||
| 2016-08-10 | Bisgaier Charles PhD Chair & Chief Scientific Off. | Conversion · 8% Convertible Subordinated Promissory Notes | −0 | 0 | ||
| 2016-08-04 | SASSINE ANDY Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2016-08-04 | LICHTINGER PEDRO Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2016-08-04 | KOUSKY KENNETH W Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2016-08-04 | Hawryluk P. Kent Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2016-08-04 | Gullans Steven R. Ph.D. Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2016-08-04 | Sooch Mina President & CEO | Grant or award · Employee Stock Option (right to buy) | +360,000 | 360,000 | ||
| 2016-08-04 | Reno Seth Chief Commercial Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2016-08-04 | Oniciu Carmen Daniela Vice President | Grant or award · Employee Stock Option (right to buy) | +102,000 | 102,000 | ||
| 2016-08-04 | MATHIESEN JEFFREY S Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +210,000 | 210,000 | ||
| 2016-08-04 | Lowenschuss David CLO & Secretary | Grant or award · Employee Stock Option (right to buy) | +78,000 | 78,000 | ||
| 2016-08-04 | Bisgaier Charles PhD Chief Scien. Officer & Chair | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 |
Page 9 of 9 · 177 trades